Epithalon and the Pineal Gland: Implications for Sleep and Aging
Used both diagnostically and therapeutically for GH deficiency, sermorelin has proven effective for increasing growth hormone synthesis and providing related benefits
Glutathione: actively combats dullness and provides the face with clarity
Your health status influences response, with stress levels determining glutathione use rates
Ozeki et al (2022) found that GLP1-RA semaglutide effectively reduces body adiposity while maintaining the skeletal muscle mass in obese Type 2 Diabetic patients. Xiang et al (2023) had similar findings, semaglutide can reduce the weight and fat of obese patients while effectively maintaining muscle mass and muscle strength. Chen et al (2023) conducted a 3-month intervention using dulaglutide in patients with Type 2 Diabetes, noting , dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in body fat was independently associated with improved glucose control during dulaglutide therapy. With an increasing number of physicians and researchers relying on GLP-1 therapies for clinical care and research, it will continue to be crucial to track sensitive changes in body composition across different patient populations
Although several lipidomics studies have shown that NAFLD patients demonstrated abnormal glycerolipid metabolism (summarized in 3.1), the underlying molecular mechanisms are still largely unclear
